TEVA PHARMACEUTICAL INDUSTRIES LTD

By person

23 insiders · 54 transactions

25.8×

Richard Francis holds 25.8 times base salary in stock. $43.86M of shares against $1.70M in salary for 2025.

Salary from the company's own proxy. The shares are what Richard Francis last reported holding, valued at $37.25, the price Ordinary Shares was last bought or sold at on the open market here, on 21 Aug 2026.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Francis Richard D

President and CEO

—

$31.26M (7) scheduled

−$31.26M

1,177,529

0.1010%

$43.86M

+855.1%

Kalif Eliyahu Sharon

EVP, Chief Financial Officer

—

$20.73M (3) scheduled

−$20.73M

65,621

0.0056%

$2.44M

−67.8%

Sabag Mark

See "Remarks"

—

$13.15M (4)

−$13.15M

80,760

0.0069%

$3.01M

−78.9%

Daniell Richard

EVP, Europe Commercial

—

$12.08M (8) scheduled

−$12.08M

55,755

0.0048%

$2.08M

—

MIGNONE ROBERTO

Director

—

$8.46M (3)

−$8.46M

487,407

0.0418%

$18.16M

−54.7%

Hughes Eric A

See "Remarks"

—

$4.17M (5) scheduled

−$4.17M

134,877

0.0116%

$5.02M

—

Fox Christine

EVP, U.S. Commercial

—

$2.75M (5)

−$2.75M

63,647

0.0055%

$2.37M

—

Lippman Evan

EVP, Business Development

—

$2.16M (3) scheduled

−$2.16M

25,591

0.0022%

$953.26K

—

Weiss Amir

Chief Accounting Officer

—

$1.41M (5)

−$1.41M

13,071

0.0011%

$486.89K

+152.4%

Shields Matthew

EVP, Global Operations

—

$1.40M (3) scheduled

−$1.40M

0.0000%

$0.00

—

Jover Placid

See "Remarks"

—

$895.46K (2) scheduled

−$895.46K

6,774

0.0006%

$252.33K

—

Savage Brian

Interim Chief Legal Officer

—

$163.76K (4) scheduled

−$163.76K

10,914

0.0009%

$406.55K

+1,377%

Satchi-Fainaro Ronit

Director

—

$15.46K (1)

−$15.46K

111,986

0.0096%

$4.17M

+26.9%

Zaks Tal Zvi

Director

—

$592.71 (1)

−$592.71

73,247

0.0063%

$2.73M

+49.1%

Elstein Amir

Director

—

2,118,455

0.1818%

$78.91M

+1.2%

BARER SOL J

Director

—

448,011

0.0384%

$16.69M

+9.5%

LIEBERMAN GERALD M

Director

—

130,149

0.0112%

$4.85M

+22.8%

Crane Rosemary A

Director

—

127,739

0.0110%

$4.76M

+23.3%

Nisen Perry

Director

—

119,807

0.0103%

$4.46M

+25.2%

Vergis Janet S.

Director

—

73,697

0.0063%

$2.75M

+15.0%

Shalev Varda

Director

—

22,504

0.0019%

$838.27K

+74.8%

Lichtenstein Chen

Director

—

19,296

0.0017%

$718.78K

—

McAvoy David R.

EVP, Chief Legal Officer

—

13,027

0.0011%

$485.26K

—

Individual transactions

Insider

Date

Role

Action

Price

Amount

Weiss Amir

21 Aug 2026

Chief Accounting Officer

Sold after exercise

2,500

$37.63

$94.08K

Weiss Amir

21 Aug 2026

Chief Accounting Officer

Sold after exercise

6,945

$37.61

$261.22K

Hughes Eric A

3 Aug 2026

See "Remarks"

Sold after exercise

25,578

$34.88

$892.05K

Jover Placid

3 Aug 2026

See "Remarks"

Sold after exercise

12,827

$34.88

$447.35K

Francis Richard D

5 Jun 2026

President and CEO

Sold after exercise

6,153

$34.35

$211.36K

Shields Matthew

3 Jun 2026

EVP, Global Operations

Sold after exercise

16,195

$32.87

$532.33K

Lippman Evan

14 May 2026

EVP, Business Development

Sold after exercise

35,912

$35.58

$1.28M

Lippman Evan

14 May 2026

EVP, Business Development

Sold after exercise

5,746

$35.58

$204.47K

Shields Matthew

5 Mar 2026

EVP, Global Operations

Sold after exercise

17,295

$31.67

$547.70K

Savage Brian

5 Mar 2026

Interim Chief Legal Officer

Sold after exercise

1,127

$31.67

$35.69K

Jover Placid

5 Mar 2026

See "Remarks"

Sold after exercise

14,150

$31.67

$448.11K

Daniell Richard

5 Mar 2026

EVP, Europe Commercial

Sold after exercise

17,295

$31.67

$547.70K

Hughes Eric A

5 Mar 2026

See "Remarks"

Sold after exercise

9,533

$31.67

$301.89K

Fox Christine

5 Mar 2026

EVP, U.S. Commercial

Sold after exercise

7,924

$31.67

$250.94K

Francis Richard D

5 Mar 2026

President and CEO

Sold after exercise

20,025

$31.67

$634.16K

Savage Brian

4 Mar 2026

Interim Chief Legal Officer

Sold after exercise

1,186

$32.46

$38.50K

Savage Brian

4 Mar 2026

Interim Chief Legal Officer

Sold after exercise

1,489

$32.46

$48.34K

Fox Christine

4 Mar 2026

EVP, U.S. Commercial

Sold after exercise

9,098

$32.46

$295.36K

Hughes Eric A

4 Mar 2026

See "Remarks"

Sold after exercise

11,277

$32.46

$366.10K

Daniell Richard

4 Mar 2026

EVP, Europe Commercial

Sold after exercise

37,372

$32.95

$1.23M

Daniell Richard

4 Mar 2026

EVP, Europe Commercial

Sold after exercise

20,461

$32.46

$664.26K

Daniell Richard

4 Mar 2026

EVP, Europe Commercial

Sold after exercise

33,512

$32.46

$1.09M

Francis Richard D

4 Mar 2026

President and CEO

Sold after exercise

23,393

$32.46

$759.44K

Hughes Eric A

3 Mar 2026

See "Remarks"

Sold after exercise

68,685

$32.36

$2.22M

Hughes Eric A

3 Mar 2026

See "Remarks"

Sold after exercise

12,077

$32.36

$390.81K

Francis Richard D

3 Mar 2026

President and CEO

Sold after exercise

412,032

$32.36

$13.33M

Francis Richard D

3 Mar 2026

President and CEO

Sold after exercise

30,903

$32.36

$1.00M

Savage Brian

3 Mar 2026

Interim Chief Legal Officer

Sold after exercise

1,274

$32.36

$41.23K

Daniell Richard

3 Mar 2026

EVP, Europe Commercial

Sold after exercise

66,735

$32.36

$2.16M

Daniell Richard

3 Mar 2026

EVP, Europe Commercial

Sold after exercise

62,250

$32.36

$2.01M

Francis Richard D

15 Feb 2026

President and CEO

Sold after exercise

286,122

$34.22

$9.79M

Francis Richard D

15 Feb 2026

President and CEO

Sold after exercise

161,656

$34.22

$5.53M

Sabag Mark

9 Dec 2025

See "Remarks"

Sold after exercise

98,168

$28.70

$2.82M

Sabag Mark

9 Dec 2025

See "Remarks"

Sold after exercise

118,724

$28.75

$3.41M

Daniell Richard

9 Dec 2025

Exec. VP, European Commercial

Sold after exercise

115,468

$28.68

$3.31M

Fox Christine

20 Nov 2025

EVP, Head of U.S. Commercial

Sold after exercise

28,229

$24.78

$699.52K

Show all 54 transactions →

TEVA PHARMACEUTICAL INDUSTRIES LTD

By person

Individual transactions

What was left out